Address
Biogen Idec New Ventures
5200 Research Place
San Diego, CA 92122
United States
Recent investment activity
KANDO id: 3002
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 10 of 10Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Eos Biotechnology Inc | Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea | N/A | ||||
Hydra Biosciences Inc | N/A | |||||
Knopp Biosciences LLC | A drug discovery and development company focused on delivering breakthrough treatments in neurological disorders | N/A | ||||
Optherion Inc | N/A | |||||
Probiodrug | Biopharmaceutical company focused on the development of innovative small molecule drugs. | Venture | ||||
Probiodrug | Biopharmaceutical company focused on the development of innovative small molecule drugs. | Series B | ||||
Raven Biotechnologies Inc | A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. | Series D | ||||
Virdante Pharmaceuticals Inc | A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. | Series A | ||||
AVEO Pharmaceuticals Inc | Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. | N/A | ||||
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | Series C |
Team
Employee | Position | ||
---|---|---|---|
John M Dunn |